CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+2.35%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7.89B
AUM Growth
+$7.89B
(-2%)
Cap. Flow
-$195M
Cap. Flow
% of AUM
-2.48%
Top 10 Holdings %
Top 10 Hldgs %
74.12%
Holding
84
New
2
Increased
15
Reduced
23
Closed
7
Top Buys
| 1 |
HDFC Bank
HDB
|
$93.2M |
| 2 |
Procter & Gamble
PG
|
$25.3M |
| 3 |
Alibaba
BABA
|
$16.3M |
| 4 |
Align Technology
ALGN
|
$2.97M |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$2.63M |
Top Sells
| 1 |
Visa
V
|
$130M |
| 2 |
Ecolab
ECL
|
$38.3M |
| 3 |
Baidu
BIDU
|
$28.6M |
| 4 |
Thermo Fisher Scientific
TMO
|
$26.4M |
| 5 |
Exxon Mobil
XOM
|
$20.4M |
Sector Composition
| 1 | Financials | 22.39% |
| 2 | Consumer Discretionary | 17.21% |
| 3 | Healthcare | 13.13% |
| 4 | Consumer Staples | 11.8% |
| 5 | Communication Services | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Edwards Lifesciences
EW
$47.8B
| $21.1M | 0.27% | 95,747 -25,196 | -21% | -$5.54M |
|
27
Illumina
ILMN
$15.8B
| $17.6M | 0.22% | 57,978 +3,473 | +6% | +$1.06M |
|
28
DexCom
DXCM
$29.5B
| $16.5M | 0.21% | 110,240 -11,709 | -10% | -$1.75M |
|
29
Insulet
PODD
$23.9B
| $16.4M | 0.21% | 99,672 -53,000 | -35% | -$8.74M |
|
|
30
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $16.4M | 0.21% | 808,464 +130,000 | +19% | +$2.63M |
|
31
Exact Sciences
EXAS
$8.98B
| $16.2M | 0.21% | 178,932 | – | – |
|
32
Teladoc Health
TDOC
$1.37B
| $15.9M | 0.2% | 234,834 | – | – |
|
33
Teleflex
TFX
$5.59B
| $15.3M | 0.19% | 45,000 | – | – |
|
34
Humana
HUM
$36.5B
| $14.1M | 0.18% | 55,000 | – | – |
|
35
Centene
CNC
$14.3B
| $13.7M | 0.17% | 317,306 | – | – |
|
|
BHVN
36
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $13M | 0.16% | 311,751 | – | – |
|
37
Heron Therapeutics
HRTX
$207M
| $13M | 0.16% | 702,069 | – | – |
|
|
TVRD
38
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $12.9M | 0.16% | 703,460 | – | – |
|
|
LHCG
39
DELISTED
LHC Group LLC
LHCG
| $12.6M | 0.16% | 110,657 | – | – |
|
40
NovoCure
NVCR
$1.38B
| $12.5M | 0.16% | 166,784 -41,275 | -20% | -$3.09M |
|
41
Vertex Pharmaceuticals
VRTX
$100B
| $11.6M | 0.15% | 68,557 | – | – |
|
42
TherapeuticsMD
TXMD
$12.8M
| $11.6M | 0.15% | 3,189,834 | – | – |
|
|
AMRN
43
Amarin Corp
AMRN
$311M
| $11.5M | 0.15% | 761,329 | – | – |
|
44
BioMarin Pharmaceuticals
BMRN
$11.2B
| $11M | 0.14% | 163,851 | – | – |
|
45
Sarepta Therapeutics
SRPT
$1.78B
| $10.9M | 0.14% | 145,329 +30,000 | +26% | +$2.26M |
|
|
AERI
46
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $10.7M | 0.14% | 556,142 +100,000 | +22% | +$1.92M |
|
|
47
Align Technology
ALGN
$10.3B
| $10.6M | 0.13% | 58,428 +16,428 | +39% | +$2.97M |
|
48
Glaukos
GKOS
$5.5B
| $10.5M | 0.13% | 167,212 -42,053 | -20% | -$2.63M |
|
|
STML
49
DELISTED
Stemline Therapeutics, Inc.
STML
| $10.4M | 0.13% | 998,677 +140,595 | +16% | +$1.46M |
|
|
AXDX
50
DELISTED
Accelerate Diagnostics
AXDX
| $9.74M | 0.12% | 524,683 | – | – |
|